Amplia Therapeutics Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amplia Therapeutics Ltd with three other
companies in this sector in AUSTRALIA :
Lbt Innovations Limited
(2021
sales of 1.43 million Australian Dollars [US$1.05 million]
of which 100%
was Conducting researching, developing and c),
Proteomics International Laboratories Ltd
(1.47 million Australian Dollars [US$1.07 million]
of which 100%
was single business), and
Biotron Limited
(1.46 million Australian Dollars [US$1.07 million]
of which 100%
was Biomedical Industry).
Sales Analysis.
Sales increased substantially in 2021:
Amplia Therapeutics Ltd reported sales of A$1.53 million (US$1.12 million)
for the
fiscal
year ending
March of 2021.
This
represents
an
increase of 4,380.4%
versus 2020, when the company's sales were A$34,227.00 .